Search Results 671-680 of 19274 for Myocardium

1. A Study of Grapiprant and Pembrolizumab in Patients with Advanced or Progressive MSS Colorectal Cancer - Mayo Clinic

   Clinically significant (i.e., active) cardiovascular disease: cerebral vascular accident/stroke (< 6 months prior to enrollment), myocardial infarction (< 6 ...

2. A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors - Mayo Clinic

   myocardial infarction, unstable angina, symptomatic congestive heart failure, serious uncontrolled cardiac arrhythmia) within 6 months before randomization.

3. Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma - Mayo Clinic

   ... myocardial infarction, or stroke within 6 months prior to the planned first dose of tazemetostat; or ventricular cardiac arrhythmia requiring medical treatment ...

4. Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome - Mayo Clinic

   History of myocardial infarction ≤ 6 months prior to registration, or congestive heart failure requiring use of ongoing maintenance therapy for life ...

5. A Study to Evaluate Stereotactic Radiosurgery Versus Hippocampal-Avoidant Whole Brain Radiotherapy for 10 or Fewer Brain Metastases from Small Cell Lung Cancer - Mayo Clinic

   Transmural myocardial infarction within the last 6 months;; Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration ...

6. MRI Study To Identify Functional and Structural Changes That Correlate with Patient Improvement When Imaging the Brain Pre-and-Post Erenumab - Mayo Clinic

   History of myocardial infarction, stroke, transient ischemic attack, unstable angina, coronary artery bypass surgery, or other revascularization procedures ...

7. MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients - Mayo Clinic

   Patients with a history of known coronary artery disease or a myocardial infarction within the last 12 months; Patients with a known history of serious ...

8. A Study Comparing BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM) - Mayo Clinic

   ... myocardial infarction within 6 months of screening. QTcF prolongation (defined as a QTcF > 480 msec). Active, clinically significant Electrocardiogram (ECG) ...

9. Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma - Mayo Clinic

   - Myocardial infarction within 6 months prior to day 1 of treatment - Clinically significant arrhythmias or conduction block (premature atrial contractions ...

10. CATALINA-2: A Clinical Study Of TORL-1-23 In Platinum-resistant Ovarian Cancer.

    Myocardial infarction less than 6 months before start of study drug 4. Anti-arrhythmic therapy (beta blockers are permitted) 5. Any unstable ischemic ...